title: p53-specific CD8+ T-cell responses in individuals with cutaneous squamous cell carcinoma.
abstract: BACKGROUND
  Systemic immunosuppression is a significant risk factor for cutaneous squamous cell carcinoma (SCC). p53 is mutated and overexpressed in up to 90% of cutaneous SCC lesions. Despite considerable evidence that the immune response is important in the control of cutaneous SCC, there are no studies documenting potential tumour-associated antigens.
  
  
  OBJECTIVE
  We tested the hypothesis that individuals with cutaneous SCC have functional circulating CD8+ T cells specific for p53.
  
  
  METHODS
  Interferon-gamma immunosorbent assays were used to screen peripheral blood mononuclear cells for reactivity to six p53-derived HLA-A*0201-restricted epitopes from HLA-A*0201-positive patients and controls.
  
  
  RESULTS
  We observed significantly elevated frequencies of p53-specific CD8+ T cells in seven of 26 individuals with cutaneous SCC and in one of 10 controls. The degree of lymphocytic infiltrate significantly correlated with the frequency of CD8+ T cells specific for p53 epitopes, but not with control epitopes.
  
  
  CONCLUSIONS
  Overall, these data suggest that p53 may represent a target for CD8+ T cells in a proportion of individuals with cutaneous SCC.
authors.affiliation: MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.
authors.forename: A P
authors.initials: AP
authors.lastname: Black
authors.forename: A
authors.initials: A
authors.lastname: Bailey
authors.forename: L
authors.initials: L
authors.lastname: Jones
authors.forename: R J
authors.initials: RJ
authors.lastname: Turner
authors.forename: K
authors.initials: K
authors.lastname: Hollowood
authors.forename: G S
authors.initials: GS
authors.lastname: Ogg
mesh_terms: D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D005260:Female; D015234:HLA-A Antigens / Q000032:analysis; D015789:HLA-A2 Antigen; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008297:Male; D012878:Skin Neoplasms / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D016159:Tumor Suppressor Protein p53 / Q000276:immunology* / Q000378:metabolism
chemical_list: D018984:Epitopes, T-Lymphocyte; D015234:HLA-A Antigens; C435939:HLA-A*02:01 antigen; D015789:HLA-A2 Antigen; D016159:Tumor Suppressor Protein p53; D007371:Interferon-gamma